However, pre-cell death assessment of CSA expression at 48 h after CHST11 knockdown (Fig. 4h), showed a significant reduction of CSA chains in PC-3 cells (Fig. 4i), supporting the idea that CHST11 is driving CSA expression in prostate cancer. The gene discussed is CHST11; the disease is prostate carcinoma.